Transcat (NASDAQ:TRNS) Reaches New 52-Week High at $116.19

Transcat, Inc. (NASDAQ:TRNS - Get Free Report)'s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as $116.19 and last traded at $114.98, with a volume of 52441 shares trading hands. The stock had previously closed at $111.35.

Analyst Upgrades and Downgrades

TRNS has been the topic of several research reports. HC Wainwright restated a "buy" rating and set a $124.00 price target on shares of Transcat in a research note on Tuesday, April 16th. Oppenheimer restated an "outperform" rating and set a $125.00 price target (up previously from $120.00) on shares of Transcat in a research note on Thursday, April 18th. Finally, TheStreet upgraded Transcat from a "c+" rating to a "b" rating in a research note on Wednesday, January 31st.

Transcat Price Performance

The firm has a 50 day simple moving average of $108.64 and a 200-day simple moving average of $102.39. The company has a quick ratio of 2.81, a current ratio of 3.37 and a debt-to-equity ratio of 0.01. The company has a market cap of $1.02 billion, a PE ratio of 88.45 and a beta of 0.59.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its earnings results on Monday, January 29th. The scientific and technical instruments company reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.03. Transcat had a return on equity of 9.32% and a net margin of 4.16%. The company had revenue of $65.17 million for the quarter, compared to analyst estimates of $63.36 million. As a group, research analysts predict that Transcat, Inc. will post 1.34 earnings per share for the current fiscal year.

Insider Buying and Selling at Transcat

In other Transcat news, Director Charles P. Hadeed sold 700 shares of Transcat stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $113.00, for a total value of $79,100.00. Following the transaction, the director now owns 22,678 shares in the company, valued at $2,562,614. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Transcat news, CEO Lee D. Rudow sold 5,000 shares of the firm's stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $111.30, for a total value of $556,500.00. Following the completion of the sale, the chief executive officer now owns 108,478 shares of the company's stock, valued at $12,073,601.40. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Charles P. Hadeed sold 700 shares of the firm's stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $113.00, for a total value of $79,100.00. Following the completion of the sale, the director now directly owns 22,678 shares of the company's stock, valued at approximately $2,562,614. The disclosure for this sale can be found here. Insiders have sold 8,073 shares of company stock worth $900,023 over the last quarter. Insiders own 4.20% of the company's stock.

Institutional Investors Weigh In On Transcat

Institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its holdings in Transcat by 13.3% in the third quarter. Vanguard Group Inc. now owns 425,378 shares of the scientific and technical instruments company's stock worth $41,674,000 after acquiring an additional 49,828 shares in the last quarter. Monashee Investment Management LLC acquired a new stake in shares of Transcat during the third quarter worth about $588,000. Quadrature Capital Ltd acquired a new stake in shares of Transcat during the third quarter worth about $2,847,000. Rice Hall James & Associates LLC lifted its holdings in shares of Transcat by 59.2% during the third quarter. Rice Hall James & Associates LLC now owns 28,781 shares of the scientific and technical instruments company's stock worth $2,820,000 after purchasing an additional 10,697 shares during the period. Finally, Conestoga Capital Advisors LLC lifted its holdings in shares of Transcat by 0.6% during the fourth quarter. Conestoga Capital Advisors LLC now owns 762,861 shares of the scientific and technical instruments company's stock worth $83,404,000 after purchasing an additional 4,805 shares during the period. Institutional investors and hedge funds own 98.34% of the company's stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.